Atom Investors LP Acquires New Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Atom Investors LP bought a new position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 24,368 shares of the real estate investment trust's stock, valued at approximately $992,000.

Other large investors also recently bought and sold shares of the company. Assetmark Inc. raised its position in shares of Omega Healthcare Investors by 1.7% in the third quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust's stock valued at $48,492,000 after buying an additional 19,542 shares during the last quarter. Daiwa Securities Group Inc. lifted its position in shares of Omega Healthcare Investors by 317.7% during the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust's stock worth $160,739,000 after purchasing an additional 3,003,845 shares in the last quarter. Caxton Associates LP acquired a new stake in Omega Healthcare Investors in the second quarter valued at approximately $1,652,000. Van ECK Associates Corp raised its holdings in Omega Healthcare Investors by 15.4% in the third quarter. Van ECK Associates Corp now owns 100,145 shares of the real estate investment trust's stock valued at $4,167,000 after acquiring an additional 13,367 shares in the last quarter. Finally, Citigroup Inc. raised its holdings in Omega Healthcare Investors by 20.1% in the third quarter. Citigroup Inc. now owns 351,529 shares of the real estate investment trust's stock valued at $14,307,000 after acquiring an additional 58,950 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company's stock.

Omega Healthcare Investors Stock Performance

Shares of Omega Healthcare Investors stock traded down $0.10 during trading on Wednesday, hitting $39.44. 1,518,281 shares of the stock were exchanged, compared to its average volume of 1,685,173. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $44.42. The stock has a market capitalization of $10.65 billion, a price-to-earnings ratio of 29.00, a price-to-earnings-growth ratio of 1.24 and a beta of 0.98. The company has a fifty day moving average price of $40.52 and a 200-day moving average price of $37.54. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10.

Omega Healthcare Investors Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.80%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors's dividend payout ratio (DPR) is presently 197.06%.

Insider Transactions at Omega Healthcare Investors

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the firm's stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the firm's stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of analysts have weighed in on OHI shares. Wells Fargo & Company reissued an "overweight" rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Scotiabank lifted their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "sector perform" rating in a research note on Monday, August 26th. BNP Paribas raised shares of Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 target price for the company in a research note on Thursday, October 31st. Truist Financial lifted their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a report on Wednesday, September 4th. Finally, Royal Bank of Canada boosted their target price on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a report on Monday, November 11th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $40.00.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.